Trial Details

Not Recruiting
Basic Information
Clinical ID c3321
Identifier EUCTR2008-002333-75-DE
Trial Title A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT) versus iron sucrose (VENOFER) for treatment of iron deficiency anaemia in patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Iron deficiency anaemia in patients with inflammatory bowel disease MedDRA version: 9.1_Level: LLT_Classification code 10055736_Term: Iron deficiency anaemia secondary to blood loss (chronic)_
Interventions Trade Name: FERINJECT 50 mg iron/ml solution for injection and infusion Pharmaceutical Form: Solution for infusion INN or Proposed INN: Ferric carboxymaltose Current Sponsor code: VIT-45 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 50- Trade Name: Venofer solution for injection, 20 mg/ml iron Pharmaceutical Form: Solution for injection CAS Number: 8047674 Other descriptive name: IRON SUCROSE Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 20-
Participant Information
Sponsor Vifor (International) Inc.
City -
Country/Region Estonia;Spain;Lithuania;Denmark;Austria;Germany;United Kingdom;Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -